Differences

This shows you the differences between two versions of the page.

--- 2016:groups:g5:start [2016/01/03 15:18] – [Questions & Suggestions] mendes
+++ 2016:groups:g5:start [2024/01/09 18:45] (current) – external edit 127.0.0.1
@@ Line 11: / Line 11: @@
 ===== Introduction =====
-Malaria eradication has been the target of several concerted global efforts, with varying degrees of success. An aspect of the disease that makes such a goal harder to achieve are the so called asymptomatic cases, in which individuals do not present clinical symptoms, but carry and transmit the parasite nonetheless. If only only symptomatic individuals are treated, a reservoir of infected hosts could maintain malaria transmission going.
+Malaria eradication has been the target of several concerted global efforts, with varying degrees of success. An aspect of the disease that makes such a goal harder to achieve are the so called asymptomatic cases, in which individuals do not present clinical symptoms, but carry and transmit the parasite nonetheless. If only symptomatic individuals are treated, a reservoir of infected hosts could maintain malaria transmission going.
-Asymptomatic malaria is common in areas of high transmission of //Plasmodium falciparum// (the most studied, and virulent, malaria parasite species). //P. vivax//, on the other hand, presents asymptomatic cases even in areas of low transmission. Moreover, //P. vivax// may develop resting stages in the liver, which can cause relapses - the reappearance of the infection weeks or months after exposure or even recovery.
+Asymptomatic malaria is common in areas of high transmission of //Plasmodium falciparum// (the most studied, and virulent, malaria parasite species). //Plasmodium vivax//, on the other hand, causes asymptomatic cases even in areas of low transmission. Moreover, //P. vivax// may develop resting stages in the liver, which can cause relapses - the reappearance of the infection weeks or months after exposure or even recovery.
 {{ https://upload.wikimedia.org/wikipedia/commons/thumb/f/fc/%22Don%27t_go_to_Bed_with_Malaria_Mosquito%22_-_NARA_-_514146.tif/lossy-page1-493px-%22Don%27t_go_to_Bed_with_Malaria_Mosquito%22_-_NARA_-_514146.tif.jpg?350 Don't go to bed with malaria mosquito }}
@@ Line 28: / Line 28: @@
 ===== References =====
-* Laishram et al. (2012) //The complexities of malaria disease manifestations with a focus on asymptomatic malaria// Malaria Journal 11:29 [[http://www.biomedcentral.com/content/pdf/1475-2875-11-29.pdf|link]]
+  * Laishram et al. (2012) //The complexities of malaria disease manifestations with a focus on asymptomatic malaria// Malaria Journal 11:29 [[http://www.biomedcentral.com/content/pdf/1475-2875-11-29.pdf|link]]
+  * Mueller et al. (2009) //Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite// The Lancet infectious diseases 9:9 p 555-566 [[http://www.sciencedirect.com/science/article/pii/S147330990970177X|link]]
-* Mueller et al. (2009) //Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite// The Lancet infectious diseases 9:9 p 555-566 [[http://www.sciencedirect.com/science/article/pii/S147330990970177X|link]]
+  * Alves et al. (2005) //Asymptomatic Carriers of Plasmodium spp. as Infection Source for Malaria Vector Mosquitoes in the Brazilian Amazon// Journal of Medical Entomology 42(5):777-779 [[http://www.bioone.org/doi/full/10.1603/0022-2585%282005%29042%5B0777:ACOPSA%5D2.0.CO%3B2|link]]
-* Alves et al. (2005) //Asymptomatic Carriers of Plasmodium spp. as Infection Source for Malaria Vector Mosquitoes in the Brazilian Amazon// Journal of Medical Entomology 42(5):777-779 [[http://www.bioone.org/doi/full/10.1603/0022-2585%282005%29042%5B0777:ACOPSA%5D2.0.CO%3B2|link]]